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ORIGINAL ARTICLE
Update on endoscopic Management of Main Pancreatic 
Duct Stones in Chronic Calcific Pancreatitis
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Pancreatic duct stones are a common complication during the natural course of chronic pancreatitis and often 
contribute to additional pain and pancreatitis. Abdominal pain, one of the major symptoms of chronic pancreatitis, 
is believed to be caused in part by obstruction of the pancreatic duct system (by stones or strictures) resulting in 
increasing intraductal pressure and parenchymal ischemia. Pancreatic stones can be managed by surgery, endoscopy, 
or extracorporeal shock wave lithotripsy. In this review, updated management of pancreatic duct stones is discussed.
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INTRODUCTION
Chronic pancreatitis is a progressive inflammatory dis-
ease of varied etiology characterized by destruction of pan-
creatic parenchyma and subsequent fibrosis [1]. Alcohol is 
a major etiological factor in most industrialized countries 
[2]. Pancreatic duct calcifications are common in patients 
with chronic pancreatitis, and up to 90% of patients with 
alcoholic chronic pancreatitis have such stones during 
long-term follow-up [3]. Pancreatic duct calculi can lead to 
an outflow obstruction of the pancreatic duct, resulting in 
upstream hypertension, increased parenchymal pressure, 
and ischemia. Pain is the predominant symptom in most 
patients with chronic pancreatitis [4]. The etiology of pain 
is multifactorial, although ductal hypertension caused by 
stones or strictures is believed to be the major cause of 
pain in patients with chronic pancreatitis [4-9]. Pancreatic 
stones can be removed in an attempt to decrease the pain. 
Additionally, restitution of pancreatic duct flow improves 
physiological function of the pancreas [10-12].
A pancreatic duct obstruction due to main pancreatic 
duct stones can often be relieved by surgical or endoscopic 
techniques or extracorporeal shock wave lithotripsy 
(ESWL). Removing pancreatic stones endoscopically is 
less invasive compared to surgery but is more likely to be 
successful when the stone burden is small and located 
only in the main duct [13,14]. In a series with a long-term 
follow-up, a good clinical outcome was recorded in two-
thirds of patients, particularly in those with short duration 
pain before treatment [15]. Due to the complexity of pan-
creatic stone management, these patients are best man-
aged in large referral centers. 
PATHOPHYSIOLOGY
Pancreatic juice is supersaturated with calcium. Calcium 
is kept in solution by HCO3, citrate, and pancreatic stone Choi Ek and Lehman GA.  Endoscopic management of pancreatic stones    21
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protein (PSP), and these factors are lower in patients with 
chronic pancreatitis [16]. Alcohol and chronic pancreatitis 
decrease the secretion of PSP, which causes the crystal-
lization and deposition of calcium carbonate and the 
formation of stones [17]. Pancreatic duct strictures cause 
stagnation of pancreatic juice and enhance the formation 
of pancreatic stones. Hypercalcemia may cause a rise in 
the level of calcium in pancreatic juice, which accelerates 
the formation of pancreatic stones in patients with hyper-
parathyroidism. Calcium precipitates as CaCO3. Protein 
intraductal precipitates form soft stones and are relatively 
easy to sweep out endoscopically. A small portion of the 
stones have a protein core and calcium rim. 
DIAGNOSIS
The finding of diffuse pancreatic calcifications on plain 
abdominal films is quite specific for chronic pancreatitis. 
Focal calcifications may be observed in cystic and islet 
cell tumors of the pancreas and in peripancreatic vascular 
calcifications. Plain abdominal radiographs or barium 
studies may reveal pancreatic calcification with or without 
evidence of a mass. Pancreatic calcification can be seen in 
up to 30% of patients with chronic pancreatitis on a plain 
abdominal X-ray [18]. Ultrasonography displays dilated 
pancreatic ducts and stones but it is limited because the 
pancreas (particularly pancreatic head) cannot be ade-
quately visualized in some patients due to overlying bowel 
gas or body habitus [2]. The advent of newer imaging mo-
dalities such as computed tomography (CT) has improved 
the ability to detect pancreatic calcification [19]. Specific 
imaging of the duct system with endoscopic retrograde 
cholangiopancreatography (ERCP) or magnetic resonance 
cholangiopancreatography has the advantage of providing 
detailed images of the duct system and pancreatic stones. 
Dilation of the duct system upstream to the stone indicates 
a hydrostatic obstructive effect. Main duct stones cause 
a greater upstream hydrostatic effect than that of side 
branch stones, which often have little upstream paren-
chyma.
MANAGEMENT
In the past, treatment for painful obstructing main 
pancreatic duct stones was a surgical lateral pancreatico-
jejunostomy and open duct stone removal. Over the last 25 
years, endoscopic techniques to remove main pancreatic 
duct stones have been developed using methods analogous 
to bile duct stone removal. Simple stones can be extracted 
using various endoscopic techniques such as balloon or 
basket sweeping. Larger and impacted stones typically re-
quire lithotripsy or surgery [20]. 
Multiple series have demonstrated that removing ob-
structing stones from the main pancreatic duct improves 
symptoms in the majority of patients with chronic pancre-
atitis [13,21]. In randomized endoscopic and surgical ther-
apy trials, surgery is superior for long-term pain reduction 
in patients with painful obstructive chronic pancreatitis 
[22,23]. However, endoscopic therapy may be preferred 
because of its lower degree of invasiveness, reserving 
surgery as second-line therapy for patients in whom endo-
scopic therapy fails. Endoscopic therapy may reduce, de-
lay, or eliminate the need for surgical procedures and can 
predict the response to surgical therapy [24,25]. Adjuvant 
endoscopic approaches such as pancreatic sphincterotomy, 
intraductal lithotripsy, and pancreatic duct stricture di-
lation may be needed. Pain relief from all treatments in 
patients with alcoholic pancreatitis is poor if drinking con-
tinues. 
Medical management
Oral pancreatic enzyme supplements, a low fat diet, and 
analgesics are standard management for patients with 
chronic pancreatitis with or without duct stones. These 
therapies do not affect stone size or stone formation. Such 
treatments are aimed at decreasing pancreatic juice pro-
duction and hydrostatic pressure by inhibiting the release 
of cholecystokinin and thereby inhibiting exocrine paren-
chymal stimulation [26]. No medicines are readily avail-
able to dissolve stones. Trimethadione, an old anticonvul-
sant, dissolves pancreatic calcium stones in some settings 
[27,28]. However, due to hepatic toxicity of this medicine, 
it has not received wide usage. Thus, further studies are 
needed. 
Surgery
Surgical removal of pancreatic duct stones is a man-
agement option. The objectives of simpler surgery are to 
remove obstructing calculi, decompress obstructed ducts, 
and preserve pancreatic tissue as well as adjacent organs. 22    The korean Journal of Internal Medicine Vol. 27, no. 1, March 2012
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The decision to perform surgery for patients with pancre-
atic stones depends on many factors, including the diam-
eter of the main duct, presence of main duct stricture(s), 
associated pseudocyst(s), simultaneous cancer concerns, 
associated duodenal or biliary obstruction, the extent of 
the main duct vs. side branch duct stones, symptom sever-
ity, and operative tolerance. Operations are categorized as 
follows: resective, decompressive (drainage), denervative, 
and combination surgery. This brief surgical review will 
only focus on decompressive or drainage procedures, and 
the most common is a lateral pancreaticojejunostomy (Pu-
estow procedure). This operation is best suited for patients 
with stones in a dilated main pancreatic duct (preferred 
≥ 8 mm), which permits mucosa to mucosa anastomosis. 
Main pancreatic duct strictures can be simultaneously 
treated.
A recent report indicated that the modified Puestow pro-
cedure is effective for pain relief (-90%) and is safe (5.7% 
of complication) during a 37-month follow-up [29]. In two 
prospective studies, surgery was more effective compared 
with endoscopy for treating painful chronic pancreatitis 
(many also had stones) [22,23]. This latest study had sev-
eral limitations. A very high incidence of strictures (84%) 
was noted in the endoscopy group, and these patients were 
probably treated with inadequate short-term stenting 
(median, 27 weeks). Recently, the same author reported 
the results of a 79-month follow-up of the same group of 
patients [30]. In that report, 68% of the patients treated by 
endoscopy required additional drainage compared with 5% 
in the surgery group (p = 0.001). Moreover, 47% of the pa-
tients in the endoscopy group eventually underwent sur-
gery. Additionally, surgery was superior for pain relief (80% 
vs. 38%; p = 0.042) and quality of life and pancreatic func-
tion were comparable. Overall, these conclusions can be 
applied to patients with stones located behind strictures. 
Patients with stones in the main pancreatic duct without 
strictures are generally treated successfully with endos-
copy and/or ESWL. Surgery is often considered second-
line therapy for patients in whom endoscopic therapy fails. 
Surgical drainage is associated with a mortality rate of 
up to 5%, and long-term prognosis is not as good because 
pain may recur in up to 50% of patients within 5 years 
after surgery [31-33]. Even if the superiority of surgery in 
terms of pain relief for unselected patients is confirmed, 
an intermediate step between analgesics and surgery is 
desirable due to the drawbacks of surgery such as invasive-
ness, cost, and possibility of pain relapse even after major 
surgical procedures. 
Endoscopic management
The attractive feature of endoscopic procedures is that 
they offer an alternative to surgery. The goal of endoscopic 
treatment for chronic painful pancreatitis with pancreatic 
duct stones is clearance of calculi from the duct, thus re-
lieving the obstruction and pain [13,14,21,34]. Nonsurgical 
removal of obstructing pancreatic stones is challenging. 
Endoscopic extraction of pancreatic duct calculi is usually 
more difficult than extracting bile duct stones because 
pancreatic stones are generally speculated and hard and 
are impacted behind strictures on many occasions [13,35]. 
The best candidates for endoscopic removal are main duct 
stones of the head or body with upstream main pancreatic 
duct dilation. Approximately 50% of pancreatic stones can 
be removed effectively by standard techniques, includ-
ing endoscopic sphincterotomy or stone retrieval with a 
balloon, basket, and/or forceps alone [13,35,36]. Adding 
ESWL increases clearance rates to 60-90%. Patients with 
extensive stones of the whole gland or side branch duct 
stones without main pancreatic duct dilatation are poor 
candidates for endoscopic removal of pancreatic duct 
stones [37,38]. 
Encouraging short- and long-term follow-up (-5 years) 
results showing improvements in pain (77-100% and 54-
86%, respectively) have been reported [15,37]. In a large 
series of 1,000 patients with chronic pancreatitis who 
were treated endoscopically with long-term follow-up, 
65% of patients with strictures and/or stones showed pain 
improvement after endotherapy [39]. Others have re-
ported similar outcomes, with clinical improvement rates 
of approximately 70% [40]. Although most studies have 
suggested that endotherapy does not improve pancreatic 
function, one secretin-enhanced magnetic resonance chol-
angiopancreatography study suggested that pancreatic 
exocrine function improves after endoscopic therapy [41]. 
Endoscopic techniques include pancreatic sphincter-
otomy, stone retrieval (using balloons, baskets, or rat tooth 
forceps), stent placement, and mechanical lithotripsy 
[13,34,35,42]. A case series report (four cases) indicated 
that endoscopic balloon dilation (12-15 mm) of the pancre-
atic orifice after sphincterotomy is a safe technique that 
facilitates the removal of large radiolucent stones from 
the main pancreatic duct [43]. Further studies are needed Choi Ek and Lehman GA.  Endoscopic management of pancreatic stones    23
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before routine use of such large balloons can be recom-
mended. An alternative method is to break the large stones 
into small pieces so that they can be more easily extracted 
through the papilla. This can be done using mechanical 
lithotripsy, intraductal electrohydraulic lithotripsy (EHL), 
and ESWL. 
Several studies have reported that pain relapse occurs 
more frequently with incomplete stone removal [44-46]. In 
contrast, other series have reported no difference in pain 
relapse rates between complete and incomplete removal 
groups [14,47]. In one study, all patients whose pain re-
lapsed had intraductal pancreatic stones, suggesting that 
the main cause of pain relapse is recurrent (or remnant) 
pancreatic stones [44]. Failure to achieve pain relief de-
spite adequate clearance of the pancreatic duct stones in-
dicates other mechanisms of pain in patients with chronic 
pancreatitis.
Pancreatic sphincterotomy
In most patients, pancreatic sphincterotomy (with or 
without a biliary sphincterotomy) via the major or minor 
papilla is performed to facilitate removal of pancreatic 
stones. This is necessary, as most symptomatic stones have 
already failed to pass through the intact papilla spontane-
ously. A pancreatic sphincterotomy can be performed with 
a needle-knife incision over a guiding pancreatic stent or 
with a pull-type sphincterotome passed over a guidewire. 
The risks of pancreatic sphincterotomy are equivalent to 
biliary sphincterotomy and include early complications of 
acute pancreatitis (2-7%), bleeding (0-2%), perforations 
(< 1%), and late complications of sphincter stenosis (up to 
10%) [48-50]. 
Extraction balloons, baskets, and forceps 
These devices are used to sweep or capture pancreatic 
duct stones to deliver stones, sludge, and debris out of the 
duct system and into the small-bowel lumen. Extraction 
balloons are very safe to use during ERCP [51]. Unlike 
stone removal baskets, extraction balloons have no chance 
of becoming trapped inside the pancreatic duct because 
the balloon can simply be deflated [51]. Complication rates 
from such balloon use are very low. The greatest limiting 
factor for balloons is their fragility (they break when pull-
ing against sharp edged stone) and inability to remove 
larger stones.
Stones captured with an open basket can be removed 
by withdrawing the basket from the duct and pulling the 
stone out into the small intestinal lumen. Standard biliary 
baskets are partially effective. Smaller pancreatic stone 
baskets are more effective if the duct lumen is < 5 mm. 
Some baskets can be used to forcefully crush stones, a pro-
cess known as mechanical lithotripsy [52]. The greatest 
limitation to basket use is the inability to capture a stone 
within a < 6-mm-diameter duct. Stone extraction baskets 
are associated with a greater risk of complications than ex-
traction balloons. Although uncommon, stone extraction 
baskets can become trapped (impacted) in the pancreatic 
ducts when grasping a stone that is larger than the down-
stream duct. A variety of endoscopic, ESWL, intervention-
al radiological, and surgical techniques have been used to 
remedy this situation [53-56]. 
Rat tooth forceps can also be used to capture stones in 
the distal 1-2 cm of the main duct. Use of forceps is rela-
tively safe compared to baskets; however, inserting the 
forceps into the pancreatic duct can be difficult, resulting 
in trauma of the pancreatic duct.
Dilation and stenting of pancreatic ductal strictures
Stricture dilation may be required to facilitate stone 
removal or stent placement (Fig. 1). Benign strictures of 
the main pancreatic duct are generally due to inflamma-
tion and fibrosis around the main pancreatic duct. High-
grade strictures require dilation prior to insertion of the 
endoprosthesis. A guidewire must be maneuvered up-
stream through the narrowing before stenting or dilation 
of the stricture with a balloon or dilating catheter. Pancre-
atic duct strictures due to chronic pancreatitis are often 
densely fibrotic; thus, simple balloon dilation alone does 
not generally result in a satisfactory long-term response. 
Therefore, a benign stricture of the main pancreatic duct is 
usually managed by placing one or multiple plastic stents. 
Limited trials have been conducted using metal stents for 
benign strictures of the pancreatic duct [57,58]. The goal 
of stenting is to progressively dilate the stricture over 6-12 
months with larger stents until the stricture narrowing 
has disappeared, which requires three to five ERCP ses-
sions. The optimum duration of stent placement, stent 
number and diameter, and degree of balloon dilation are 
not well known. Post stenting mild pancreatitis occurs in 
5-10% of patients. Late complications are mainly related 
to stent migration and occlusion, which present with pain, 
pancreatitis, or infection [12]. Additionally, pancreatic 24    The korean Journal of Internal Medicine Vol. 27, no. 1, March 2012
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duct stents may produce ductal changes adjacent to the 
stricture; however, these changes may improve with time 
[59,60]. Further research with covered and uncovered 
metal stents is needed.
Intraductal mechanical lithotripsy
Mechanical lithotripsy using a through-the-scope me-
chanical lithotripter is technically difficult and has limited 
success with large pancreatic calculi, particularly when 
capturing the stones is difficult [61]. Data on mechanical 
lithotripsy for pancreatic duct stones are limited but sug-
gest that this procedure is performed rarely and carries 
an increased risk for complications when compared with 
lithotripsy for biliary stones [61]. The complication rate of 
pancreatic mechanical lithotripsy appears to be threefold 
greater than that for biliary mechanical lithotripsy [52]. 
The most common complication is a trapped/broken bas-
ket (87%) due to hard stones [52]. Acute pancreatitis and 
pancreatic duct disruption also occur. We use this tech-




Few data are available regarding intraductal EHL for 
pancreatic duct stone fragmentation [62], which must be 





Figure 1. Endoscopic removal of main pancreatic duct stones via the minor papilla. (A) Pancreatogram via major papilla shows blockage 
of main pancreatic duct suggestive of pancreas divisum. (B) A pancreatic duct stricture (arrowhead) and multiple filling defects (arrows) 
were observed in the main pancreatic duct. (C) This stricture was dilated using a controlled radial expansion balloon after a pancreatic 
sphincterotomy. Waist (arrow) of the expanding balloon. (D) No filling defect in the main pancreatic duct was observed after complete 
stone removal. A pancreatic duct stricture still existed, which was treated with pancreatic stenting.Choi Ek and Lehman GA.  Endoscopic management of pancreatic stones    25
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cialized mother-daughter scope system. EHL has the ad-
vantage of delivering high energy to a tightly focused area 
of the stone. The high energy delivered carries the risk of 
duct injury including perforation if directed at the duct 
wall [63]. We have used the “SpyGlass” pancreatoscope to 
treat two patients (unpublished data). Further studies are 
needed.
ESWL
A significant advancement in pancreatic duct stone re-
moval has been achieved with the application of ESWL for 
fragmentation. Once fragmented, stone pieces may exit 
spontaneously or with the aid of ERCP techniques. ESWL 
has been used to facilitate the removal of pancreatic duct 
stones during ERCP (Fig. 2). Some studies have reported 
high stone clearance success rates with ESWL, whereas 
others have had less impressive results [14,32]. ESWL 
overcomes the problem of stone size by fragmenting the 
stones and reducing the stone burden, thus facilitating 
endoscopic clearance of the duct [24,64,65]. ESWL, which 
works by concentrating focused shock waves on stones, 
was first used in the field of gastroenterology by Sauer-
bruch et al. [66,67] to fragment gall bladder stones and was 
used later for pancreatic duct stones. Radiopaque stones 
can be easily targeted by ESWL under fluoroscopy; ra-
diolucent stones can be targeted using ultrasound-guided 
shock wave lithotripsy or by injection of contrast through 
a nasopancreatic catheter. ESWL of main pancreatic duct 
Figure 2. Extracorporeal shock wave lithotripsy (ESWL) to facilitate removal of pancreatic duct stones. (A) Two pancreatic calcifica-
tions (arrows) are seen on the plain film. (B) Two filling defects (arrows) were observed in the main pancreatic duct, which were difficult 
to remove due to their large size. (C) Radiopaque stones seen alongside the pancreatic stent were fragmented successfully after ESWL. (D) 
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stones is largely considered complementary to endoscopic 
techniques for stone clearance but has even been proposed 
as a possible first-line treatment [6,15,68,69]. 
Early reports of ESWL for obstructing pancreatic duct 
calculi describe a high degree of technical and clinical ef-
ficacy [42,46,47]. A recent large review of the ESWL litera-
ture concluded that ESWL results in complete duct clear-
ance in 50% of patients [65]. Complete removal rates differ 
among institutions. These differences may be due to the 
type of lithotriptor used, the power setting, the number of 
shocks delivered, the number of treatment sessions, and 
differences regarding the definition of complete removal of 
pancreatic stones among institutions. Our group prelimi-
narily reported intravenous secretin-aided fragmentation 
of main pancreatic duct stones by creating a fluid-filled 
space at the circumference of the stones and flushing out 
the stone fragments during ESWL [70]. In that report, se-
cretin showed a significantly higher rate of complete main 
pancreatic duct stone clearance. Long-term follow-up 
studies have shown that ESWL combined with endoscopic 
drainage of the pancreatic duct relieves pain and may 
avoid the need for surgery in approximately two-thirds of 
patients [15,68]. In a randomized study comparing the re-
sponse of ESWL alone (n = 26) and after ESWL combined 
with endoscopy (n = 29), the investigators concluded that 
ESWL alone is a safe, effective, and preferred treatment 
for select patients [69]. Our suggested general approach for 
managing patients with pancreatic duct stones is summa-
rized in Fig. 3.
ESWL is a relatively safe technique [69]. The minor 
Symptomatic patients with pancreatic
calcifications seen seen at radiologic exam
Medical treatment
Large size (≥ 5 mm) stones with 










ESWL × 1-3 until
stones look
fragmented, consider
iv secretin if stone is
> 10 mm and multiple
ERCP if calcifications
remain on CT or plain
film
Repeat ESWL for 
failure to extract most
stone(s)
Small size stones mostly
side branch location
Large size (≥ 5 mm) stones with other
complex features such as duodenal
narrowing and inflammatory head mass
Surgery
Figure 3. Our suggested algorithm for patients with pancreatic duct stones. ERCP, endoscopic retrograde cholangiopancreatography; 
ESWL, extracorporeal shock wave lithotripsy; CT, computed tomography.Choi Ek and Lehman GA.  Endoscopic management of pancreatic stones    27
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complications from ESWL include skin or duodenal con-
tusions, exacerbation of pancreatitis, mild abdominal 
discomfort, and asymptomatic hyperamylasemia. Acute 
pancreatitis attributed to ESWL has been reported in 
6.3-12.5% of patients after ESWL “alone” for treating cal-
cified chronic pancreatitis [6,71]. Serious complications 
after ESWL have been reported in < 1% of patients [72]. 
We observed one patient with a right renal subcapsular 
hematoma. This treatment is often painful and requires 
general anesthesia or large doses of analgesics. One study 
has reported that epidural anesthesia produces effective 
analgesia for these procedures [73]. 
ESWL for pancreatic duct stones is being performed in 
South Korea although publications are limited. Cost-effec-
tiveness should be considered in the overall management. 
 
CONCLUSION
Pancreatic duct stones were often considered unimport-
ant or untreatable. However, several effective modalities 
to treat pancreatic duct stones including ESWL, as well as 
endoscopic and surgical options, are now available. The 
patient should help decide whether one surgical session 
or two or more less-invasive sessions are preferred. Ad-
ditional prospective randomized studies are needed to 
further establish the optimal strategy for pancreatic duct 
stone management.
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